Anzeige
Mehr »
Dienstag, 16.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
160 Leser
Artikel bewerten:
(1)

Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing Healthcare Innovation | Valuates Reports

BANGALORE, India, Sept. 16, 2025 /PRNewswire/ --

What is the Market Size of Medical Device OEM/ODM/CDMO?

The global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Valuates Reports Logo

Download Free Sample Data on Medical Device OEM/ODM/CDMO Market

What Are the Key Factors Driving the Growth of the Medical Device OEM/ODM/CDMO Market?

The medical device OEM/ODM/CDMO market is evolving into a critical enabler of global healthcare innovation and accessibility. Companies are increasingly relying on external partners to meet rising demands for speed, personalization, compliance, and digital integration. The convergence of manufacturing excellence, regulatory support, and technological expertise is transforming the industry landscape.

Strategic collaborations are blurring traditional boundaries between OEMs and service providers, creating co-development models that foster innovation at scale. As patient-centric care, global supply chain resilience, and digital health continue to reshape healthcare delivery, this market emerges as a cornerstone for scalable, compliant, and quality-focused medical device production across geographies and therapeutic domains.

Source from Valuates Reports: https://reports.valuates.com/market-reports/QYRE-Auto-0N20035/global-medical-device-oem-odm-cdmo?utm_source=Prnewswire&utm_medium=Referral

TRENDS INFLUENCING THE GROWTH OF THE MEDICAL DEVICE OEM/ODM/CDMO MARKET:

CDMOs serve as critical partners in the medical device ecosystem by offering comprehensive support from concept development to final production. Their services include design assistance, prototyping, regulatory documentation, and large-scale manufacturing, helping original manufacturers streamline processes and reduce time-to-market. By outsourcing to specialized CDMOs, companies benefit from advanced technologies and quality management systems without significant internal investment. This model also enables scalability, allowing rapid shifts in production based on demand. CDMOs often maintain compliance with global regulatory bodies, simplifying entry into international markets. Their collaborative approach drives product innovation and improves operational efficiency. As medical devices become more complex, the reliance on CDMOs continues to rise, pushing their role to the forefront of the global supply chain.

ODM services allow companies to launch proprietary medical devices without investing in the entire R&D and manufacturing process. These providers design and produce ready-to-brand devices that can be quickly introduced into the market, giving clients faster access to sales channels and reducing overall development cycles. ODMs ensure regulatory compliance and incorporate high-quality materials and tested designs, maintaining patient safety while lowering client risk. This approach is particularly attractive to startups and mid-sized firms looking to expand their portfolios efficiently. With in-house engineering and testing teams, ODMs adapt quickly to market trends and regulatory changes. Their ability to innovate and deliver turnkey solutions has made them a strategic pillar in accelerating the medical device sector's commercial reach.

Consumables are essential components in medical device applications and represent a significant share of recurring revenue in this market. These include catheters, syringes, diagnostic strips, and tubing used in single-use or semi-disposable devices. The demand for consumables is driven by the rise in chronic diseases, minimally invasive procedures, and home-based healthcare services. Manufacturers focus on biocompatibility, sterilization standards, and consistent quality, which are critical for patient safety. OEMs and CDMOs continuously optimize production to meet volume and cost requirements. Additionally, private-label consumables enable healthcare providers to offer branded alternatives. As healthcare systems emphasize efficiency and infection control, the need for reliable, regulatory-compliant consumables grows, reinforcing their role in expanding the medical device OEM/ODM/CDMO ecosystem.

Strict global regulatory frameworks have elevated the importance of compliance-focused services in the medical device OEM/ODM/CDMO market. Service providers must ensure that devices meet safety, performance, and documentation standards laid out by authorities such as the FDA, EMA, and PMDA. This includes managing clinical evaluations, risk assessments, and post-market surveillance. By embedding regulatory expertise into product development, manufacturers reduce approval delays and facilitate smoother international launches. Companies offering compliance-as-a-service are in high demand, especially among smaller firms lacking in-house regulatory departments. As cross-border trade in medical devices increases, consistent adherence to diverse compliance rules becomes a core operational priority. This regulatory integration strengthens trust among stakeholders and accelerates product adoption across regions.

Personalization is emerging as a transformative force within the medical device market, especially for wearables, prosthetics, and implants. OEMs are increasingly investing in custom-fit solutions that cater to individual anatomy and health conditions. This requires sophisticated design tools, data integration, and advanced manufacturing capabilities, all of which are often provided by CDMOs and ODMs. Personalized devices offer improved treatment outcomes and patient satisfaction, fostering adoption across therapeutic areas. 3D printing and AI-assisted design further accelerate this trend. Service providers that can offer quick, compliant, and scalable personalization options are gaining competitive advantage. This shift toward individualized care is reshaping how devices are designed, produced, and delivered, opening new pathways for growth.

Maintaining high-quality standards and managing risk across the supply chain is fundamental to sustaining credibility in the medical device space. OEMs depend on their ODM and CDMO partners to uphold rigorous quality assurance protocols, including audits, traceability, and non-conformance tracking. These practices are embedded at every stage from mate innovative sourcing, and proactive issue resolution. Service providers with robust quality systems ensure fewer recalls and regulatory flags, protecting both brand reputation and patient outcomes. As regulatory expectations tighten globally, the ability to demonstrate quality and reliability becomes a critical market differentiator for manufacturers and their outsourcing partners.

The demand for faster product development cycles has led to streamlined innovation processes in the OEM/ODM/CDMO model. Time-sensitive market opportunities, especially in diagnostics and wearable health tech, require agile development paths. CDMOs and ODMs facilitate iterative prototyping, accelerated testing, and scalable pilot runs. This speed-to-market advantage supports first-mover benefits, especially in competitive segments. Close collaboration between design, engineering, and regulatory teams allows immediate feedback and refinement. Joint innovation centers and open R&D models are becoming more prevalent, promoting cross-pollination of ideas. As healthcare needs evolve, rapid innovation capability becomes a decisive growth factor, enabling companies to address unmet clinical demands efficiently and remain relevant in dynamic market conditions.

Claim Yours Now! https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-0N20035&lic=single-user

What are the major product types in the Medical device OEM/ODM/CDMO market?

  • OEM
  • ODM
  • CDMO

What are the main applications of the Medical device OEM/ODM/CDMO market?

  • Equipment
  • Consumables

Key Players in the Medical device OEM/ODM/CDMO market:

  • Brands
  • Original Equipment Manufacturer
  • ASAHI INTECC
  • Solteam Medical
  • Dr. Japan
  • Fuji Systems
  • SANYOSEIKO CO., LTD
  • Top Glove
  • Hartalega
  • Kossan
  • Supermax
  • Jabil
  • Flex Ltd
  • Integer Holdings
  • Nemera
  • Hitachi
  • JEOL
  • APT Medical
  • Nanfang Medical
  • Jointown
  • Tianyi Medical
  • Shifeng Medical
  • BrosMed Medical
  • Winner Medical
  • Changzhou Hualian Health Dressing
  • Blue Sail Medical
  • Zhonghong Pulin Medical Products
  • Gerresheimer
  • Syrma Johari MedTech Healthcare
  • ZMl Electronics
  • Suzhou Zhenpu medical device
  • Caremed Medical
  • Insighters
  • Canon Medica

Which region dominates the Medical device OEM/ODM/CDMO Market based on region

North America dominates the market due to its strong manufacturing base, advanced regulatory ecosystem, and high adoption of outsourced development models. The United States leads in medical device exports and investments in CDMO partnerships, particularly in surgical instruments and diagnostic devices.

Europe follows closely, with countries like Germany, Switzerland, and Ireland offering specialized manufacturing hubs and a skilled workforce.

Purchase Regional Report on Medical device OEM/ODM/CDMO

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

What are some related markets to the medical device OEM/ODM/CDMO market?

-Medical Device Mounts Market was valued at US$ 571 million in the year 2024 and is projected to reach a revised size of US$ 933 million by 2031, growing at a CAGR of 7.4% during the forecast period.

-EMS and ODM Market was estimated to be worth US$ 774840 million and is forecast to reach approximately US$ 1175950 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

-Medical Device Contract Manufacturing Market revenue was US$ 73100 million in 2022 and is forecast to a readjusted size of US$ 131970 million by 2029 with a CAGR of 8.7% during the review period (2023-2029).

-Medical Sector Contract Electronic Manufacturing Market

-Medical Supplies Market was estimated to be worth US$ 202430 million in 2023 and is forecast to a readjusted size of US$ 329030 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030.

-Medical Device Labeling market was valued at US$ 942.4 million in 2023 and is anticipated to reach US$ 1494.2 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

-Connected Medical Devices market was valued at US$ 28490 million in 2023 and is anticipated to reach US$ 47780 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.

-Medical Device CDMO and CRO Market

-Contract Research Organization (CRO) and CDMO for Pharmaceutical Market

-Pharmaceutical CDMO Services Market

-Tablet ODM & EMS Market

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

Contact Us
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335
Explore our blogs & channels:
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
YouTube: https://www.youtube.com/@valuatesreports6753

Localized content:
Korean: https://www.facebook.com/valuateskorean
Spanish: https://www.facebook.com/valuatesspanish
Japanese: https://www.facebook.com/valuatesjapanese
Spanish: https://valuatesreportspanish.blogspot.com/
Korean: https://valuateskorean.blogspot.com/
German: https://valuatesgerman.blogspot.com/
Japanese: https://valuatesreportjapanese.blogspot.com/

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medical-device-oemodmcdmo-industry-forecast-cagr-of-7-5-to-2031-amid-growing-healthcare-innovation--valuates-reports-302557837.html

© 2025 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.